Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Molecular characterizations of Nop16 in murine mammary tumors with varying levels of c-Myc.

Kundel DW, Stromquist E, Greene AL, Zhdankin O, Regal RR, Rose-Hellekant TA.

Transgenic Res. 2012 Apr;21(2):393-406. doi: 10.1007/s11248-011-9529-3. Epub 2011 Aug 24.

2.

Short-term prophylactic tamoxifen reduces the incidence of antiestrogen-resistant/estrogen receptor-positive/progesterone receptor-negative mammary tumors.

Rose-Hellekant TA, Skildum AJ, Zhdankin O, Greene AL, Regal RR, Kundel KD, Kundel DW.

Cancer Prev Res (Phila). 2009 May;2(5):496-502. doi: 10.1158/1940-6207.CAPR-09-0002. Epub 2009 Apr 28.

3.

Estrogen receptor-positive mammary tumorigenesis in TGFalpha transgenic mice progresses with progesterone receptor loss.

Rose-Hellekant TA, Schroeder MD, Brockman JL, Zhdankin O, Bolstad R, Chen KS, Gould MN, Schuler LA, Sandgren EP.

Oncogene. 2007 Aug 9;26(36):5238-46. Epub 2007 Mar 5.

Supplemental Content

Loading ...
Support Center